Fed. Circ. Upholds $16.8M Fees Award For Takeda
By Jesse Greenspan ( December 8, 2008, 12:00 AM EST) -- Takeda Pharmaceutical Co. Ltd. will take home $16.8 million in legal fees after a federal appeals court panel upheld a district court's ruling that generic-drug maker Mylan Laboratories Inc. and subsidiary Alphapharm Pty. Ltd. acted improperly when they challenged Takeda's patent for the diabetes treatment Actos....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.